Randomized, controlled trial of entecavir versus placebo in children with hepatitis B envelope antigen-positive chronic hepatitis B-Reference-Cited by-同舟云学术

Randomized, controlled trial of entecavir versus placebo in children with hepatitis B envelope antigen-positive chronic hepatitis B

Published:2015-10-16 Issue:2 Volume:63 Page:377-387
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Jonas Maureen M.¹,Chang Mei-Hwei²,Sokal Etienne³,Schwarz Kathleen B.⁴,Kelly Deirdre⁵,Kim Kyung Mo⁶,Ling Simon C.⁷,Rosenthal Philip⁸,Oraseanu Dumitru⁹,Reynolds Laurie¹⁰,Thiry Alexandra¹⁰,Ackerman Peter¹⁰

Affiliation:

1. Boston Children's Hospital; Boston MA

2. National Taiwan University Hospital; Taipei Taiwan

3. Cliniques Universitaires St Luc, Université Catholique de Louvain; Brussels Belgium

4. Johns Hopkins Children's Center; Baltimore MD

5. Birmingham Children's Hospital; Birmingham UK

6. Asan Medical Center Children's Hospital, University of Ulsan College of Medicine; Seoul Republic of Korea

7. The Hospital For Sick Children, and Department of Pediatrics; University of Toronto; Toronto Canada

8. University of California; San Francisco CA

9. Grigore Alexandrescu Emergency Hospital for Children; Bucharest Romania

10. Bristol-Myers Squibb; Wallingford CT

Funder

funded by Bristol-Myers Squibb

Publisher

Wiley

Subject

Hepatology

Reference39 articles.

1. Chronic hepatitis B in children and adolescents;Paganelli;J Hepatol,2012

2. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology;Sokal;Hepatology and Nutrition. J Hepatol,2013

3. ® 2014

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovir;Journal of Clinical Virology;2024-10

2. Hepatitis B Management in the Middle East: A Narrative Review of Current Antiviral Treatments;Gastrointestinal Disorders;2024-09-12

3. Expert Consensus on the Prevention and Treatment of Chronic Hepatitis B in Children;Infectious Diseases & Immunity;2024-06-12

4. Functional cure is associated with younger age in children undergoing antiviral treatment for active chronic hepatitis B;Hepatology International;2024-02-20

5. Should Indications for Antiviral Therapy for Hepatitis B Be Broadened to Include Immune-Tolerant Patients, Inactive Carriers, or Patients in the “Gray Zone”?;Current Hepatology Reports;2024-02-12